Mupirocin (as calcium) 2%; oint. Eradication of nasal colonization of methicillin-resistant S. aureus (MRSA) in adult patients and healthcare workers in certain institutional settings during outbreaks ...

A large multi-state study by the Centers for Disease Control and Prevention, the Harvard Pilgrim Health Care Institute, HCA Healthcare, and the University of California, Irvine has found that a nasal ...

To our knowledge, this is the first report of a pharmacy program implemented to improve the outcomes of an S. aureus decolonization protocol. After implementation of the program, adherence to nasal ...

NASHVILLE, Tenn. & ORANGE, Calif. & ATLANTA & BOSTON--(BUSINESS WIRE)--A large multi-state study by the Centers for Disease Control and Prevention, Harvard Pilgrim Health Care Institute, HCA ...

generic cream GlaxoSmithKline announced a recall of 13 lots of Bactroban (mupirocin) Nasal Ointment, Bactroban Ointment, and Bactroban Cream. This recall is a precautionary measure due to potential ...

Please provide your email address to receive an email when new articles are posted on . “Mupirocin is the gold-standard topical treatment for nasal decolonization, but there are reports of increasing ...

The FDA has cited SmithKline Beecham for disseminating misleading promotional materials for Bactroban Nasal, a product used to eradicate methicillin-resistant Staphylococcus aureus (MRSA).

Review the side-effects of Mupirocin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. BACTROBAN nasal ointment contains the active ingredient mupirocin ...

Data were collected for seven months before program implementation and seven months after program implementation. During the preimplementation period, 8917 patients were admitted to one of the ...

NASHVILLE, Tenn. & ORANGE, Calif. & ATLANTA & BOSTON, Oct. 10, 2023 – A large multi-state study by the Centers for Disease Control and Prevention, the Harvard Pilgrim Health Care Institute, HCA ...